Pulmonx Corp Stock Investor Sentiment

LUNG Stock  USD 5.69  0.14  2.40%   
Roughly 75% of Pulmonx Corp's investor base is looking to short. The analysis of overall sentiment of trading Pulmonx Corp stock suggests that many investors are alarmed at this time. The current market sentiment, together with Pulmonx Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Pulmonx Corp stock news signals to limit their universe of possible portfolio assets.
  

Pulmonx Corp Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Pulmonx Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at www.macroaxis.com         
Disposition of 2221 shares by Glendon French of Pulmonx Corp at 6.5 subject to Rule 16b-3
Macroaxis News
few days ago at news.google.com         
Technical Pivots with Risk Controls - Stock Traders Daily
Google News at Macroaxis
over a week ago at news.google.com         
Pulmonx director French Glendon E. III sells shares worth 29,625 - Investing.com
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 2221 shares by Glendon French of Pulmonx Corp at 6.5 subject to Rule 16b-3
Macroaxis News
over a week ago at news.google.com         
Disposition of 2326 shares by Glendon French of Pulmonx Corp at 6.53 subject to Rule 16b-3
Google News at Macroaxis
over two weeks ago at news.google.com         
Brokerages Set Pulmonx Co. Price Target at 12.75 - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
On The My Stocks Page - Stock Traders Daily
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 1184 shares by Geoffrey Rose of Pulmonx Corp at 10.6 subject to Rule 16b-3
Macroaxis News
over a month ago at simplywall.st         
Pulmonx Repeat Insider Selling Not A Positive Indicator
Simply Wall St News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Geoffrey Rose of 69100 shares of Pulmonx Corp at 9.3 subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
Pulmonx Co. Receives Consensus Rating of Moderate Buy from Brokerages - MarketBeat
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
5,730 Shares in Pulmonx Co. Acquired by 272 Capital LP
news
over a month ago at thelincolnianonline.com         
Pulmonx Price Target Lowered to 8.00 at Wells Fargo Company
news
over a month ago at news.google.com         
Pulmonxs Neutral Rating Reiterated at Citigroup - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Jacobs Levy Equity Management Inc. Cuts Holdings in Pulmonx Co. - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pulmonx Corp that are available to investors today. That information is available publicly through Pulmonx media outlets and privately through word of mouth or via Pulmonx internal channels. However, regardless of the origin, that massive amount of Pulmonx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pulmonx Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pulmonx Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pulmonx Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pulmonx Corp alpha.

Pulmonx Corp Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
FMR LLC Bolsters Stake in Pulmonx Corp - GuruFocus.com
11/12/2024
2
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
11/20/2024
3
Insider Selling Pulmonx Co. Director Sells 20,000 Shares of Stock
11/27/2024
4
Disposition of 410 shares by David Lehman of Pulmonx Corp at 6.18 subject to Rule 16b-3
12/04/2024
5
Disposition of 1184 shares by Geoffrey Rose of Pulmonx Corp at 10.6 subject to Rule 16b-3
12/05/2024
6
Pulmonxs Neutral Rating Reiterated at Citigroup - MarketBeat
12/11/2024
7
Pulmonx Co. Receives Consensus Rating of Moderate Buy from Brokerages - MarketBeat
12/17/2024
8
Acquisition by Geoffrey Rose of 69100 shares of Pulmonx Corp at 9.3 subject to Rule 16b-3
12/23/2024
9
Disposition of 2326 shares by Glendon French of Pulmonx Corp at 6.53 subject to Rule 16b-3
01/16/2025
10
Disposition of 2221 shares by Glendon French of Pulmonx Corp at 6.5 subject to Rule 16b-3
01/17/2025

Complementary Tools for Pulmonx Stock analysis

When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Money Managers
Screen money managers from public funds and ETFs managed around the world